About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
https://soho2018.org/
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Plenary Sessions
Breakfast with the Expert
Session VI: Multiple Myeloma
Program of Events
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
AML Next Questions: MRD and Discussion Intensive Induction, Immune Stimulation, & Clonally Directed Therapy
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Richard Stone
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Richard Stone
0 views
October 24, 2018
Comments
0
Login to view comments.
Click here to Login
Featured Video
08:18
Insights from 2023 ASH Annual Meeting
Treatment Strategies for Hematocrit Control in PV
Feat.
A. Zhou
Featured Video
16:51
Incyte
Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk
Feat.
C. Harrison
Session V: Acute Myeloid Leukemia
20:09
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
AML: State of the Art Update
Feat.
H. Erba
17:02
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
NGS At Diagnosis: Uses And Pitfalls
Feat.
C. Gibson
16:15
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Immune Therapy Approaches in AML: Antigen Targets, Novel Antibodies …
Feat.
N. Daver
14:08
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
DEBATE: Use Gemtuzumab in Most AML Patients vs Use Gemtuzumab in CBF…
Feat.
R. Walter
15:05
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
DEBATE: Use Gemtuzumab in Most AML Patients vs Use Gemtuzumab in CBF…
Feat.
G. Roboz
12:42
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Durable Response with Venetoclax in Combination with Decitabine or A…
Feat.
C. DiNardo
10:20
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract AML 152: Hypomethylating Agents versus Intensive Chemo…
Feat.
C. Talati
07:11
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract SCT 020: Incidence, Risk Factors and Treatment Respons…
Feat.
D. Rivera
04:19
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
AML Next Questions: MRD and Discussion Intensive Induction, Immune S…
Feat.
R. Stone
